Kim Kamdar

Kim Kamdar

Chairman bei SERA PROGNOSTICS, INC.

Vermögen: 68 034 $ am 31.03.2024

56 Jahre
Health Technology
Finance
Health Services

Profil

Kim Puloma Kamdar founded Truvian Sciences, Inc. in 2015, where she is working as Chairman.
Dr. Kamdar also founded Aryzun Pharmaceuticals and Seraphina Therapeutics, Inc., where she is working as Chairman.
Dr. Kamdar also currently works at Sera Prognostics, Inc., as Chairman from 2023, ROX Medical, Inc., as Director, One Palmer Square Associates VII LLC, as Director, San Diego Venture Group, as Director, The Hastings Center, as Director, Epic Sciences, Inc., as Director, Connect Foundation, as Director, SalveoDx, as Director, Evofem Biosciences, Inc., as Independent Director, Singular Genomics Systems, Inc., as Independent Director from 2017, Alume Biosciences, Inc., as Director from 2020, Epitel, Inc., as Director & Partner, Access Youth Academy, as Director, Pleno, Inc., as Director, Domain Associates LLC, as Partner from 2011, One Palmer Square Associates VIII LLC, as Managing Member, Domain LLC, as Partner from 2011, Adjuvant Capital LP, as Advisory Partner, and Medical Excellence Capital LLC, as Managing Partner from 2021.
Dr. Kamdar also formerly worked at Aspen Neuroscience, Inc., as Chairman & Chief Executive Officer, Obalon Therapeutics, Inc., as Chairman from 2020 to 2021, Corthera, Inc., as Director, Novartis International AG, as Research Director, Achaogen, Inc., as Director, BiPar Sciences, Inc., as Director, Adastra Pharmaceuticals, Inc., as Director, Syndax Pharmaceuticals, Inc., as Independent Director from 2006 to 2017, Omniome LLC, as Director, Sonexa Therapeutics, Inc., as Director, Nuon Therapeutics, Inc., as Director, Altair Therapeutics, Inc., as Director, Neothetics, Inc., as Director from 2011 to 2014, Ariosa Diagnostics, Inc., as Director from 2010 to 2015, MPM BioImpact, Inc, as Principal in 2004, Torrey Mesa Research Institute, as Program Leader, and Bill & Melinda Gates Foundation, as Advisor.
Dr. Kamdar received her doctorate degree in 1995 from Emory University and undergraduate degree in 1988 from Northwestern University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
08.06.2023 6 629 ( 0,02% ) 60 324 $ 31.03.2024
25.05.2023 15 000 ( 0,02% ) 7 710 $ 31.03.2024
15.03.2024 0 ( -.--% ) - $ 31.03.2024

Aktive Positionen von Kim Kamdar

UnternehmenPositionBeginn
SERA PROGNOSTICS, INC. Chairman 08.06.2023
SINGULAR GENOMICS SYSTEMS, INC. Director/Board Member 01.05.2017
EVOFEM BIOSCIENCES, INC. Director/Board Member 01.01.2018
Private Equity Investor 01.01.2005
Connect Foundation Director/Board Member -
SalveoDx Director/Board Member -
Founder 01.01.2015
One Palmer Square Associates VII LLC Director/Board Member -
Consultant / Advisor -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Alle aktiven Positionen von Kim Kamdar

Ehemalige bekannte Positionen von Kim Kamdar

UnternehmenPositionEnde
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Kim Kamdar im Detail an

Ausbildung von Kim Kamdar

Emory University Doctorate Degree
Northwestern University Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Kim Kamdar im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

41

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
SYNDAX PHARMACEUTICALS, INC.

Health Technology

SERA PROGNOSTICS, INC.

Health Services

EVOFEM BIOSCIENCES, INC.

Health Technology

SINGULAR GENOMICS SYSTEMS, INC.

Health Technology

Private Unternehmen35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

One Palmer Square Associates VII LLC

Health Technology

Health Technology

Finance

Distribution Services

Health Technology

One Palmer Square Associates VIII LLC

Aryzun Pharmaceuticals

Health Services

The Hastings Center

Health Technology

Finance

Connect Foundation

SalveoDx

Health Services

Health Services

Commercial Services

Finance

Technology Services

Commercial Services

Consumer Services

Health Services

Technology Services

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Kim Kamdar